Reccan AB

Reccan AB is dedicated to revolutionizing the detection of pancreatic cancer through innovative biotechnology research. With a focus on early diagnosis and improved prognosis, Reccan AB is committed to setting new standards in the fight against this challenging disease. The company’s vision is to significantly enhance the effectiveness of interventions and treatments by detecting pancreatic cancer at an earlier stage than currently possible.

Located at Scheeletorget 1, 223 63 Lund and within Medicon Village, the Spark in Lund, Reccan AB is driven by a mission to change the trajectory of pancreatic cancer mortality. Through dedicated research and cutting-edge technology, Reccan AB aims to provide solutions that make a tangible difference in patient outcomes. The company’s work is focused on developing methods for early detection, which is crucial for more effective treatment strategies.

Reccan AB is poised to make significant advancements in the field of medical technology. We invite the manager of Reccan AB to create a customized and exclusive company showcase and product listing on our platform, highlighting their groundbreaking work and expanding their reach within the industry.